Integrase Inhibitor | List of Frontiers open access articles

Original Research

Published on 29 Jan 2024

Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insults

in Brain Disease Mechanisms

Alexander Starr
Emily Nickoloff-Bybel
Razan Abedalthaqafi
Naela Albloushi
Kelly L. Jordan-Sciutto

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2023.1353562

4,228 views
1 citation

Original Research

Published on 12 Nov 2024

Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens

in Viral Immunology

Nicholas T. Funderburg
Susie S. Y. Huang
Calvin Cohen
Kate Ailstock
Morgan Cummings
Jean C. Lee
Brenda Ng
Kirsten White
Jeffrey J. Wallin
Bryan Downie

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488799

5,259 views
10 citations

Original Research

Published on 12 Mar 2024

Antiretroviral drugs from multiple classes induce loss of excitatory synapses between hippocampal neurons in culture

in Neuropharmacology

Hannah M. McMullan
Benjamin M. Gansemer
Stanley A. Thayer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369757

3,237 views
6 citations

Perspective

Accepted on 27 Apr 2026

Maintain, Not Obtain: Rethinking HIV Care in Sub-Saharan Africa in the Era of Dolutegravir

in Infectious Diseases: Epidemiology and Prevention

Carlo Federico Perno
Stefano Orlando
Noorjehan Abdul Majid
Hawam Sangare'
Richard Luhanga
Michele Roccucci
Loredana Andreea Silaghi
Zita Sidumo
Davide Brambilla
Susanna Ceffa

Frontiers in Public Health

177 views

Systematic Review

Published on 21 Jul 2021

Three-Drug Regimens Containing Integrase Inhibitor Show Good Efficacy and Safety in Treatment-Naive Patients With HIV-1: A Bayesian Analysis

in Drugs Outcomes Research and Policies

Ke Zhang
Yang Zhang
Xinchao Liu
Aixin Li
Meixia Gao
Jianhua Hou
Chunxiang Guo
Tong Zhang
Hao Wu
Guanzhi Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.603068

5,650 views
9 citations

Perspective

Published on 04 May 2026

Durable viral suppression in the dolutegravir era: a data-enabled, risk-stratified model for integrated HIV care in Uganda

in Infectious Diseases: Epidemiology and Prevention

Maria Magdalene Namaganda
Joyce Nakatumba Nabende
David Patrick Kateete
Charles Batte
Gerald Mboowa

Frontiers in Public Health

doi 10.3389/fpubh.2026.1794681

462 views

Clinical Trial

Published on 11 Jul 2024

Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors

in Inflammation

Abraham Saborido-Alconchel
Ana Serna-Gallego
María Trujillo-Rodriguez
Esperanza Muñoz-Muela
Ana I. Álvarez-Ríos
Carmen Lozano
Silvia Llaves-Flores
Nuria Espinosa
Cristina Roca-Oporto
Marta Herrero

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423734

4,612 views
8 citations

Original Research

Published on 11 Feb 2021

Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV

in Neuroinfectious Diseases

Raha M. Dastgheyb
Alison S. Buchholz
Kathryn C. Fitzgerald
Yanxun Xu
Dionna W. Williams
Gayle Springer
Kathryn Anastos
Deborah R. Gustafson
Amanda B. Spence
Adaora A. Adimora

Frontiers in Neurology

doi 10.3389/fneur.2021.604984

6,496 views
31 citations

Original Research

Published on 18 Oct 2023

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

in Inflammation

Hortensia Álvarez
Alicia Gutiérrez-Valencia
Ana Mariño
Abraham Saborido-Alconchel
Beatriz Calderón-Cruz
Alexandre Pérez-González
Jacobo Alonso-Domínguez
Inés Martínez-Barros
María Gallego-Rodríguez
Santiago Moreno

Frontiers in Immunology

doi 10.3389/fimmu.2023.1257725

4,666 views
6 citations

Articles

Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insults

Changes to inflammatory markers during 5 years of viral suppression and during viral blips in people with HIV initiating different integrase inhibitor based regimens

Antiretroviral drugs from multiple classes induce loss of excitatory synapses between hippocampal neurons in culture

Maintain, Not Obtain: Rethinking HIV Care in Sub-Saharan Africa in the Era of Dolutegravir

Three-Drug Regimens Containing Integrase Inhibitor Show Good Efficacy and Safety in Treatment-Naive Patients With HIV-1: A Bayesian Analysis

Durable viral suppression in the dolutegravir era: a data-enabled, risk-stratified model for integrated HIV care in Uganda

Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors

Patterns and Predictors of Cognitive Function Among Virally Suppressed Women With HIV

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors